BIOMAT Database Logo BIOMAT Database Logo

Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants. 2013

Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Laboratory of Biological Chemistry, Department of Biofunctional Chemistry, Faculty of Agriculture, Kobe University, Kobe, Hyogo, 657-8501, Japan. unotom@kobe-u.ac.jp

CYP 2A6 is a human enzyme that metabolizes many xenobiotics including coumarin, indole, nicotine and carcinogenic nitrosamines. The gene for CYP2A6 is polymorphic. There are few data available to clarify the relationship between P450 genetic variants and the metabolism of materials in food. The CYP 2A6 wild-type protein and 13 mutants (CYP2A6.1, CYP2A6.2, CYP2A6.5, CYP2A6.6, CYP2A6.7, CYP2A6.8, CYP2A6.11, CYP2A6.15, CYP2A6.16, CYP2A6.17, CYP2A6.18, CYP2A6.21, CYP2A6.23 and CYP2A6.25) were co-expressed with NADPH-cytochrome P450 reductase in E. coli. The hydroxylase activities toward 7-ethoxycoumarin, coumarin, safrole, flavanone and hydroxyflavanone were examined. Ten types of CYP2A6 variants except for CYP2A6.2, CYP2A6.5 and CYP2A6.6 showed Soret peaks (450 nm) typical of P450 in the reduced CO-difference spectra and had 7-ethoxycoumarin O-deethylase activities. CYP2A6.15 and CYP2A6.18 showed higher activities for safrole 1'-hydroxylation than CYP2A6.1. CYP2A6.25 and CYP2A6.7 had lower safrole 1'-hydroxylase activities. CYP2A6.7 had lower flavanone 6- and 2'-hydroxylase activities, whereas CYP2A6.25 had higher 6-hydroxylase activity and lower 2'-hydroxylase activity. Hydroxyflavanone was metabolized by CYP2A6.25, but was not metabolized by wild-type CYP2A6.1. These results indicate that CYP2A6.25 possessed new substrate specificity toward flavonoids.

UI MeSH Term Description Entries
D009251 NADPH-Ferrihemoprotein Reductase A flavoprotein that catalyzes the reduction of heme-thiolate-dependent monooxygenases and is part of the microsomal hydroxylating system. EC 1.6.2.4. Cytochrome P-450 Reductase,Ferrihemoprotein P-450 Reductase,NADPH Cytochrome P-450 Oxidoreductase,NADPH Cytochrome P-450 Reductase,NADPH Cytochrome c Reductase,Cytochrome P-450 Oxidase,Cytochrome P450 Reductase,Ferrihemoprotein P450 Reductase,NADPH Cytochrome P450 Oxidoreductase,NADPH Cytochrome P450 Reductase,NADPH-Cytochrome P450 Reductase,NADPH-P450 Reductase,Cytochrome P 450 Oxidase,Cytochrome P 450 Reductase,Ferrihemoprotein P 450 Reductase,NADPH Cytochrome P 450 Oxidoreductase,NADPH Cytochrome P 450 Reductase,NADPH Ferrihemoprotein Reductase,NADPH P450 Reductase,Oxidase, Cytochrome P-450,P-450 Oxidase, Cytochrome,P450 Reductase, Cytochrome,P450 Reductase, NADPH-Cytochrome,Reductase, Cytochrome P-450,Reductase, Cytochrome P450,Reductase, Ferrihemoprotein P-450,Reductase, Ferrihemoprotein P450,Reductase, NADPH-Cytochrome P450,Reductase, NADPH-Ferrihemoprotein,Reductase, NADPH-P450
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006900 Hydroxylation Placing of a hydroxyl group on a compound in a position where one did not exist before. (Stedman, 26th ed) Hydroxylations
D001189 Aryl Hydrocarbon Hydroxylases A large group of cytochrome P-450 (heme-thiolate) monooxygenases that complex with NAD(P)H-FLAVIN OXIDOREDUCTASE in numerous mixed-function oxidations of aromatic compounds. They catalyze hydroxylation of a broad spectrum of substrates and are important in the metabolism of steroids, drugs, and toxins such as PHENOBARBITAL, carcinogens, and insecticides. Microsomal Monooxygenases,Xenobiotic Monooxygenases,Hydroxylases, Aryl Hydrocarbon,Monooxygenases, Microsomal,Monooxygenases, Xenobiotic
D012451 Safrole A member of the BENZODIOXOLES that is a constituent of several VOLATILE OILS, notably SASSAFRAS oil. It is a precursor in the synthesis of the insecticide PIPERONYL BUTOXIDE and the drug N-methyl-3,4-methylenedioxyamphetamine (MDMA). Shikimol,4-Allyl-1,2-methylenedioxybenzene,Safrol,4 Allyl 1,2 methylenedioxybenzene,4-Allyl-1,2-methylenedioxybenzenes,Safroles,Safrols,Shikimols
D014644 Genetic Variation Genotypic differences observed among individuals in a population. Genetic Diversity,Variation, Genetic,Diversity, Genetic,Diversities, Genetic,Genetic Diversities,Genetic Variations,Variations, Genetic
D044950 Flavanones A group of FLAVONOIDS characterized with a 4-ketone. 2-Phenyl-Benzopyran-4-Ones,2 Phenyl Benzopyran 4 Ones

Related Publications

Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Metabolism of 7-ethoxycoumarin, flavanone and steroids by cytochrome P450 2C9 variants.
November 2017, Biopharmaceutics & drug disposition,
Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Metabolism of bilirubin by human cytochrome P450 2A6.
May 2012, Toxicology and applied pharmacology,
Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Cytochrome P450 2A6 and other human P450 enzymes in the oxidation of flavone and flavanone.
February 2019, Xenobiotica; the fate of foreign compounds in biological systems,
Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Induction of cytochrome P450 1A1 in rat liver slices by 7-ethoxycoumarin and 4-methyl-7-ethoxycoumarin.
September 1998, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Site-specific oxidation of flavanone and flavone by cytochrome P450 2A6 in human liver microsomes.
July 2019, Xenobiotica; the fate of foreign compounds in biological systems,
Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Stoichiometry of 7-ethoxycoumarin metabolism by cytochrome P450 2B1 wild-type and five active-site mutants.
October 1997, FEBS letters,
Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
An inhibitory monoclonal antibody to human cytochrome P450 2A6 defines its role in the metabolism of coumarin, 7-ethoxycoumarin and 4-nitroanisole in human liver.
April 1999, Pharmacogenetics,
Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3.
November 2008, Drug metabolism and disposition: the biological fate of chemicals,
Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Roles of NADPH-P450 reductase in the O-deethylation of 7-ethoxycoumarin by recombinant human cytochrome P450 1B1 variants in Escherichia coli.
October 2000, Protein expression and purification,
Tomohide Uno, and Yuichiro Obe, and Chika Ogura, and Tatsushi Goto, and Kohei Yamamoto, and Masahiko Nakamura, and Kengo Kanamaru, and Hiroshi Yamagata, and Hiromasa Imaishi
Marmoset pulmonary cytochrome P450 2F1 oxidizes biphenyl and 7-ethoxycoumarin and hepatic human P450 substrates.
July 2018, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!